Pharma Foods International Co., Ltd.
Tokyo Stock ExchangeTotal Valuation
Pharma Foods International Co., Ltd. carries a market capitalization of 17.43B, placing it among publicly traded companies globally. Its enterprise value stands at 27.60B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 17.43B |
| Enterprise Value | 27.60B |
Valuation Ratios
Pharma Foods International Co., Ltd. trades at a trailing price-to-earnings ratio of 11.33. The price-to-sales ratio is 0.91, and the price-to-book ratio stands at 3.49.
| PE Ratio | 11.33 |
| PS Ratio | 0.91 |
| PB Ratio | 3.49 |
| P/TBV Ratio | 2.32 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Pharma Foods International Co., Ltd. trades at an EV/EBITDA multiple of 7.64 and an EV/FCF ratio of 1,129.56. The EV/Sales ratio of 0.91 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 7.64 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.91 |
| EV / EBITDA | 7.64 |
| EV / EBIT | 7.64 |
| EV / FCF | 1,129.56 |
Financial Position
| Current Ratio | N/A |
| Quick Ratio | N/A |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | 103.29 |
Financial Efficiency
Pharma Foods International Co., Ltd. posts a return on equity of 30.16 and a return on invested capital of 11.95.
| Return on Equity (ROE) | 30.16 |
| Return on Assets (ROA) | 13.17 |
| Return on Invested Capital (ROIC) | 11.95 |
| Return on Capital Employed (ROCE) | 13.65 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.33 |
Taxes
Over the trailing twelve months, Pharma Foods International Co., Ltd. has paid 1.05B in income taxes, reflecting an effective tax rate of 30.18.
| Income Tax | 1.05B |
| Effective Tax Rate | 30.18 |
Stock Price Statistics
Pharma Foods International Co., Ltd.'s stock has declined approximately -26.73993% over the past 52 weeks. The 50-day moving average sits at 606.56, while the 200-day moving average is 689.39.
| Beta (5Y) | N/A |
| 52-Week Price Change | -26.73993% |
| 50-Day Moving Average | 606.56 |
| 200-Day Moving Average | 689.39 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Pharma Foods International Co., Ltd. generated 30.50B in revenue and converted that into 2.44B in net income, yielding earnings per share of 87.09. EBITDA reached 3.62B, while operating income came in at 3.62B.
| Revenue | 30.50B |
| Gross Profit | 23.65B |
| Operating Income | 3.62B |
| Pretax Income | 3.49B |
| Net Income | 2.44B |
| EBITDA | 3.62B |
| EBIT | 3.62B |
| Earnings Per Share (EPS) | 87.09 |
Balance Sheet
Total book value stands at 7.92B, with working capital of -19.49B providing operational flexibility.
| Cash & Cash Equivalents | N/A |
| Total Debt | N/A |
| Net Debt | 12.44B |
| Equity (Book Value) | 7.92B |
| Book Value Per Share | 282.74 |
| Working Capital | -19.49B |
Margins
Pharma Foods International Co., Ltd. operates with a gross margin of 77.56, reflecting its pricing power and cost economics. The operating margin of 11.85 and net profit margin of 7.99 provide insight into operational efficiency.
| Gross Margin | 77.56 |
| Operating Margin | 11.85 |
| Pretax Margin | 11.45 |
| Profit Margin | 7.99 |
| EBITDA Margin | 11.85 |
Stock Splits
Pharma Foods International Co., Ltd.'s most recent stock split took place on January 28, 2015 with a 1:2 split ratio.
| Last Split Date | 1/28/2015 |
| Split Ratio | 1:2 |